Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 238,882,406 papers from all fields of science
Search
Sign In
Create Free Account
eluxadoline
Known as:
5-({(4-carbamoyl-2,6-dimethyl-L-phenylalanyl)[(1S)-1-(4-phenyl-1H-imidazol-2-yl)ethyl]amino}methyl)-2-methoxybenzoic acid
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
5 relations
Broader (3)
Gastrointestinal Agents
Imidazoles
Phenylalanine
analogs & derivatives
eluxadoline 75 MG Oral Tablet
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Efficacy and Safety of Eluxadoline in IBS-D Patients Who Report Inadequate Symptom Control With Prior Loperamide Use: A Phase 4, Multicenter, Multinational, Randomized, Placebo-controlled, Double…
D. Brenner
,
C. Gutman
,
Esther Jo
American Journal of Gastroenterology
2018
Corpus ID: 87116180
Review
2017
Review
2017
▼ Eluxadoline for IBS-D
Eluxadoline for IBS-D
Drug and therapeutics bulletin
2017
Corpus ID: 46765136
Irritable bowel syndrome (IBS) is a chronic relapsing gastrointestinal problem characterised by intestinal pain and associated…
Expand
2017
2017
An evidence-based approach to IBS and CIC: Applying new advances to daily practice
W. Chey
2017
Corpus ID: 80342696
Release Date: February 1, 2017 Expiration Date: February 1, 2018 Estimated time to complete activity: 1 hour Project ID: 5472…
Expand
2017
2017
Eluxadoline: a treatment for IBS with diarrhoea in adults
S. Chaplin
2017
Corpus ID: 79926473
Eluxadoline (Truberzi) is an oral mixed opioid‐receptor agonist/antagonist licensed for the treatment of irritable bowel syndrome…
Expand
2016
2016
A Cost-Effectiveness Comparison of Alosetron, Eluxadoline, and Rifaximin in the Treatment of Irritable Bowel Syndrome with Diarrhea
Y. Li
,
Parul Gupta
,
R. Sawant
,
S. Sansgiry
2016
Corpus ID: 196467649
1.1. Objective: The recurrent and complex Irritable Bowel Syndrome (IBS) has major impact on healthcare cost and quality-of…
Expand
2016
2016
Safety and Efficacy of Eluxadoline for Diarrhea-Predominant IBS
D. Rex
2016
Corpus ID: 76375138
Eluxadoline — a poorly absorbed, orally administered opioid-receptor agonist/antagonist — has shown promise for improving…
Expand
Review
2016
Review
2016
Irritable bowel syndrome (IBS) is a functional bowel disorder characterized by chronic abdominal pain and constipation
Lisa S. Smith
,
B. Love
2016
Corpus ID: 78120668
Irritable bowel syndrome (IBS) is a functional bowel disorder characterized by chronic abdominal pain and constipation (IBS-C…
Expand
2015
2015
Schedules of Controlled Substances: Placement of Eluxadoline Into Schedule IV. Final rule.
Federal register
2015
Corpus ID: 23207241
With the issuance of this final rule, the Administrator of the Drug Enforcement Administration places the substance 5-[[[(2S)-2…
Expand
2015
2015
FDA approves eluxadoline to treat IBS-D in adults
Lauren J. VanHook
,
Kevin W. Chamberlin
2015
Corpus ID: 72953497
Few treatment options are available for irritable bowel syndrome with diarrhea. Eluxadoline acts on the nervous system to lessen…
Expand
2015
2015
NEW DRUG APPROVALS Viberzi for IBS
Eluxadoline Viberzi
,
Patheon Pharma
2015
Corpus ID: 42030135
NEW DRUG APPROVALS Viberzi for IBS Eluxadoline (Viberzi, Patheon Pharmaceuticals/Forest Pharmaceuticals) has secured FDA approval…
Expand